The Campbell Foundation
Helping Make HIV/AIDS History Since 1995
The Campbell Foundation's Trustee and Program Officer
Board of Directors
Trustee Bill Venuti
Bill has been with The Campbell Foundation for more than a decade. He joined the Board of Directors in 2000 and became the Trustee in 2011. Bill oversees the day-to-day operations of the foundation and is responsible for the integrity of its investment portfolio.
Executive Director Ken Rapkin
Ken was named Executive Director of The Campbell Foundation in January 2016. Previously, Ken served as program officer for the foundation since its inception in 1995. His role is to administer the grant program, including initial grant proposal screening.
Jeanne R. Kos
Jeanne became a member of The Campbell Foundation Board of Directors in 2013. She moved to Fort Lauderdale as a traveling critical care nurse in 1989. She later joined the staff of Holy Cross Hospital where she worked for 21 years as a nurse in ICU, administrative director and ICU manager.
“As a board member, I have been given the unique opportunity to learn about the latest cutting-edge research around the world for an HIV cure. Allocating funds for this research has been a pleasure, as well as providing hope for the future for all people living with HIV.”
Jeanne earned her master’s degree from Nova Southeastern University in 2008 and became a board certified nurse executive that same year. She is a native of Buffalo, N.Y. and graduated from D’Youville College in 1983.
Sandra J. Kristoff
Sandy joined The Campbell Foundation Board of Directors in 2012. She has worked as a senior policy consultant to New York Life on international government affairs since 1998. Prior to that, she had a 22-year career with the federal government, serving as senior vice president and chief of staff to the chairman of New York Life Insurance and earlier as senior vice president for international government issues at NYLI.
Before joining NYLI, Sandy worked at the White House as special assistant to the president and senior director for Asian Affairs at the National Security Council. In 1993, she served at the NSC as director for Asian affairs. In 1994, she was a member of the National Economic Council where she held the position of special assistant to the president and senior director for Asia Pacific Economic Affairs. Prior to her tenure at the White House, Sandy served in variety of positions, including deputy assistant secretary of state for East Asia and Pacific affairs as well as deputy, and later assistant U.S. trade representative for Asia and the Pacific.
“Having worked in a number of less developed countries, I have seen the devastation that AIDS wreaks on a population. Being part of The Campbell Foundation means no longer just observing, but rather acting to find a cure.”
She earned her bachelor’s and master’s degree from The American University and her Juris Doctor from George Washington University Law School. Sandy was born in Washington, Pa., and raised in Baltimore.
Gerald “Jerry” Nicklas became the newest member of The Campbell Foundation’s Board of Directors in 2014. He retired after 33 years with the New York State Retirement System where he worked with individuals helping to plan their own retirement. A native of Albany, N.Y., he earned his bachelor’s degree in English from University at Albany, The State University of New York.
Jerry was a snowbird for six years, before making Pompano Beach his permanent home in January 2013. After attending a Campbell Foundation fundraiser he was so impressed he became a volunteer.
“I am proud to be a part of The Campbell Foundation. Thanks to important funding sources like The Campbell Foundation, I hope that we will soon see success in the search to find a cure for HIV/AIDS."
Bob has been a member of The Campbell Foundation Board of Directors since its inception in 1995. He was born in Buenos Aires, but grew up and was educated in Miami.
Bob is a graduate of the London School of Economics and worked for several international airlines including Varig and Pan American. He moved to Australia in 1972, where he opened the first office in Sydney for Aerolineas Argentinas. He served as general manager, Pacific and Oceania, and was vice president U.S. and Canada before retiring.
“It was Richard’s dream to fund non-traditional research into finding a cure for HIV/AIDS. While there have been many breakthroughs people are still getting the disease. We need a cure. The Campbell Foundation is offering assistance in both research funding and those who have been affected. It is wonderful to be able to participate in these activities of The Campbell Foundation.”
Corklin Steinhart, MD
Corklin (Corky) Steinhart has been a member of The Campbell Foundation Board of Directors since its inception 1995.
He is Director of Research Development and Clinical Director NW Florida for CAN Community Health of Sarasota FL. He also is the Chief Medical Officer of Payer Matrix, a company specializing in providing expensive treatments for a number of diseases at affordable costs and is Distinguished Professor at the Shanghai Public Health Clinical Center in China. Corky also is on the voluntary faculty as an Assistant Professor of Internal Medicine at the University of Central Florida Medical School in Orlando, Florida.
Previously, Corky spent 13 years in the pharmaceutical industry, first at Merck where he held several regional and global medical affairs positions in HIV, HCV, antimicrobials and antifungal diseases. Subsequently, he moved to ViiV/GSK, where he was Head of Global Medical Directors.
Prior to entering the pharmaceutical industry, Corky was President of Steinhart Medical Associates in Miami, Florida, where his hospital-based practice specialized in HIV caring for more than 2,000 PLWs. During his 16 years there, he participated in numerous clinical trials and served on a number of advisory boards. He also served as Chairperson of Mercy Hospital’s Institutional Review Committee and was the founding Medical Director of Mercy Hospital’s Special Immunology Services. Corky also served as Medical Director of the Florida Caribbean AIDS Education Training Center for several years.
Corky obtained a PhD in Physiology from The Johns Hopkins University School of Hygiene and Public Health and his MD from the University of South Florida College of Medicine in Tampa. He did his post-doctoral Internal Medicine Residency at the University of Miami/Jackson Memorial Hospital.
Corky lives in Orlando with his wife Pippa and spends as much time as he can with his two young grandchildren.
Pat has been a Campbell Foundation Board member since 1995. She was the founder’s first cousin. Having lost two members of her family to AIDS, Pat says being able to read and review the various laboratory trials has been most rewarding, but even more rewarding, she says would be to see a cure.
“It makes me proud that I am able to serve with a foundation devoted to this outcome,” she says.
Pat has a bachelor’s degree from Duke University. She was born and raised in Washington, Pa., and lives in Sarasota, Fla., where she is retired. Pat has two sons in Los Angeles, Calif., who are active in the sciences.
Rob McAlister Whetstone
Rob is head of marketing and communications for the West Coast operations of Skadden, Arps, Slate, Meagher & Flom, a global law firm. Prior to joining Skadden in 2013 he was managing director and owner of a Los Angeles communications consultancy for 18 years where he advised many life science companies. Before that he worked for a New York-based public relations firm focused on the biotechnology industry.
He started his career with Creative BioMolecules where he was an associate scientist in biochemistry. He also was a special consultant at Booz Allen Hamilton. Rob earned his bachelor of science degree in bioengineering and electrical engineering from Syracuse University. Rob is the son of the foundation's founder's first cousin. He lives in Los Angeles with his wife and two sons.
"I have always enjoyed working closely with those at the forefront of science and health care and joining The Campbell Foundation provides a great opportunity to help advance the development of new and critical treatment innovations."